Arsenic trioxide rewires mantle cell lymphoma response to bortezomib

Although most of the mantle cell lymphoma (MCL) patients initially responded well to bortezomib (BTZ), the dose-dependent toxicities have greatly limited the application of BTZ to MCL. To investigate the efficacy and mechanism of arsenic trioxide (ATO) with BTZ in inducing apoptosis of MCL cells, tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ling-Ling, Liu, Yuan-Fang, Peng, Li-Jun, Fei, Ai-Mei, Cui, Wen, Miao, Sheng-Chao, Hermine, Olivier, Gressin, Remy, Khochbin, Saadi, Chen, Sai-Juan, Wang, Jin, Mi, Jian-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674002/
https://www.ncbi.nlm.nih.gov/pubmed/26310857
http://dx.doi.org/10.1002/cam4.511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674002/
https://www.ncbi.nlm.nih.gov/pubmed/26310857
http://dx.doi.org/10.1002/cam4.511

Ejemplares similares